EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access

Comparison of Outcomes of Leadless Versus Transvenous Pacemakers Following Tricuspid Valve Surgery

Tomonari M Shimoda iD, Yoshihisa Miyamoto iD, Hiroki A Ueyama iD, Shinobu Itagaki iD, Tsuyoshi Kaneko iD, Hiroshi Gotanda iD, Kosuke Inoue iD, Shinichi Fukuhara iD, Gorav Ailawadi iD, Hiroo Takayama iD, Toshiki Kuno iD, Yusuke Tsugawa iD

Journal of the American Heart Association · 21.07.2026 · 15 (14)

DOI: 10.1161/jaha.126.049636 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Journal of the American Heart Association, erschienen am 21.07.2026. Verfasst von Tomonari M Shimoda und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiothoracic Surgery Loma Linda University Loma Linda CA USA. Hauptthemen laut MEDLINE: Pacemaker, Artificial, Tricuspid Valve, Heart Valve Prosthesis Implantation, Tricuspid Valve Insufficiency. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Transvenous pacemaker implantation after tricuspid valve surgery may cause adverse outcomes due to lead–valve interactions. Although leadless pacemakers may mitigate these risks, empirical data remain limited.

Methods

We compared outcomes of leadless versus transvenous pacemakers following tricuspid surgery using a target trial emulation framework. We analyzed Medicare beneficiaries aged ≥65 years who underwent tricuspid valve surgery and received a pacemaker during the index admission between 2017 and 2021, using propensity score matching weight analysis to control for confounders. Primary outcomes were in‐hospital death and 2‐year heart failure hospitalization. Secondary outcomes included 2‐year death.

Results

We included 185 and 1336 patients in the leadless and transvenous groups, respectively. Use of leadless pacemakers increased from 6.3% in 2017 to 17.5% in 2021. Leadless pacemaker recipients more often underwent tricuspid valve replacement (29.2% versus 8.5%) while concomitant mitral surgery was less common (69.2% versus 86.8%). After adjustment, we found no evidence that in‐hospital death (adjusted odds ratio, 1.82 [95% CI, 0.65–5.13] for leadless) and 2‐year heart failure hospitalizations (subdistribution hazard ratio [HR], 0.88 [95% CI, 0.60–1.30] for leadless) differed between the 2 groups. We also found no evidence that 2‐year death (adjusted HR, 1.04 [95% CI, 0.69–1.57] for leadless) differed between groups.

Conclusions

No statistically significant differences were detected between leadless versus transvenous pacemaker implantations after tricuspid valve surgery. However, CIs were wide, and a clinically meaningful difference in either direction cannot be excluded. The study may therefore be underpowered, and the absence of echocardiographic data limits assessment of tricuspid regurgitation, warranting prospective studies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pacemaker, ArtificialTricuspid ValveHeart Valve Prosthesis ImplantationTricuspid Valve InsufficiencyHeart FailurePostoperative ComplicationsHumansFemaleAgedMaleAged, 80 and overUnited StatesHospital MortalityTreatment OutcomeEquipment DesignRetrospective StudiesRisk Factors

Stichwörter der Autor:innen

leadless pacemakerpacemakertricuspid valve surgery

Autor:innen und Institutionen

  • Department of Cardiothoracic Surgery Loma Linda University Loma Linda CA USA.
  • Department of Cardiovascular Surgery University of Tsukuba Tsukuba Japan.
  • Department of Real-world Evidence Graduate School of Medicine, The University of Tokyo Tokyo Japan.
  • Division of Cardiology Emory University School of Medicine Atlanta GA USA.
  • Division of Cardiovascular and Thoracic Surgery University of Oklahoma Health Sciences Center Oklahoma City OK USA.
  • Division of Cardiothoracic Surgery Washington University School of Medicine St. Louis MO USA.

ORCID-Profile: Tomonari M Shimoda, Yoshihisa Miyamoto, Hiroki A Ueyama, Shinobu Itagaki, Tsuyoshi Kaneko, Hiroshi Gotanda, Kosuke Inoue, Shinichi Fukuhara, Gorav Ailawadi, Hiroo Takayama, Toshiki Kuno, Yusuke Tsugawa

Zitieren

APA

Shimoda, T. M., Miyamoto, Y., Ueyama, H. A., Itagaki, S., Kaneko, T., Gotanda, H., Inoue, K., Fukuhara, S., Ailawadi, G., Takayama, H., Kuno, T., & Tsugawa, Y. (2026). Comparison of Outcomes of Leadless Versus Transvenous Pacemakers Following Tricuspid Valve Surgery. Journal of the American Heart Association, 15(14). https://doi.org/10.1161/jaha.126.049636

Vancouver

Shimoda TM, Miyamoto Y, Ueyama HA, Itagaki S, Kaneko T, Gotanda H, et al. Comparison of Outcomes of Leadless Versus Transvenous Pacemakers Following Tricuspid Valve Surgery. Journal of the American Heart Association. 2026;15(14). doi:10.1161/jaha.126.049636

BibTeX
@article{Shimoda2026,
  author = {Shimoda, Tomonari M and Miyamoto, Yoshihisa and Ueyama, Hiroki A and Itagaki, Shinobu and Kaneko, Tsuyoshi and Gotanda, Hiroshi and Inoue, Kosuke and Fukuhara, Shinichi and Ailawadi, Gorav and Takayama, Hiroo and Kuno, Toshiki and Tsugawa, Yusuke},
  title = {Comparison of Outcomes of Leadless Versus Transvenous Pacemakers Following Tricuspid Valve Surgery},
  journal = {Journal of the American Heart Association},
  year = {2026},
  volume = {15},
  number = {14},
  doi = {10.1161/jaha.126.049636}
}
Kostenlos starten →